NSE BSE
ind swift laboratories lt stock

IND SWIFT LABORATORIES LT Share Price

- - (%)
- NSE: INDSWFTLAB

IND SWIFT LABORATORIES LT Share Price Update

As of the latest trading session, IND SWIFT LABORATORIES LT share price is currently at 134.16, which is up by 3.63 from its previous closing. Today, the stock has fluctuated between 130.01 and 135.96. Over the past year, IND SWIFT LABORATORIES LT has achieved a return of 43.32 %. In the last month alone, the return has been 16.33 %. Read More...

IND SWIFT LABORATORIES LT Performance

Day Range

Low130.01 High135.96
130.35

52 Week Range

Low 81.85 High 147.20
130.35

IND SWIFT LABORATORIES LT Share Price

4870

532305

INDSWFTLAB

img img img img
No Data Available

Open Price

130.01

Prev. Close

130.53

Volume (Shares)

298431.00

Total traded value

389.00

Upper Circuit

156.63

Lower Circuit

104.42

Note: The current prices & values are delayed, Login to your account for live updates.

IND SWIFT LABORATORIES LT Fundamentals


(Standalone)

Market Cap (Cr) 792.71
PE Ratio (TTM) 1.84
Book Value / Share 125.04
Beta 0.78
ROE 11.57%
EPS (TTM) 24.63
Dividend Yield 0.00%
Net Profit Qtr (Cr) 349.59

IND SWIFT LABORATORIES LT Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 381.73
Operating Expense 310.41
Net Profit 349.59
Net Profit Margin (%) 91.58
Earnings Per Share (EPS) 59.17
EBITDA 484.34
Effective Tax Rate (%) 27.64
Particulars DEC 2023 (Values in Cr)
Revenue 276.28
Operating Expense 256.65
Net Profit 21.65
Net Profit Margin (%) 7.83
Earnings Per Share (EPS) 3.66
EBITDA 61.36
Effective Tax Rate (%) 19.02
Particulars SEP 2023 (Values in Cr)
Revenue 270.30
Operating Expense 241.23
Net Profit 30.10
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 5.09
EBITDA 70.80
Effective Tax Rate (%) 17.49
Particulars JUN 2023 (Values in Cr)
Revenue 299.01
Operating Expense 273.46
Net Profit 17.05
Net Profit Margin (%) 5.70
Earnings Per Share (EPS) 2.89
EBITDA 65.37
Effective Tax Rate (%) 45.17
Particulars MAR 2023 (Values in Cr)
Revenue 270.30
Operating Expense 241.23
Net Profit 30.10
Net Profit Margin (%) 11.13
Earnings Per Share (EPS) 5.09
EBITDA 70.80
Effective Tax Rate (%) 17.49
Particulars MAR 2024 (Values in Cr)
Revenue 1227.32
Operating Expense 1081.76
Net Profit 418.39
Net Profit Margin (%) 34.08
Earnings Per Share (EPS) 70.81
EBITDA 681.87
Effective Tax Rate (%) 27.54
Particulars MAR 2023 (Values in Cr)
Revenue 1151.96
Operating Expense 1079.40
Net Profit 42.47
Net Profit Margin (%) 3.68
Earnings Per Share (EPS) 7.19
EBITDA 228.73
Effective Tax Rate (%) 46.37
Particulars MAR 2022 (Values in Cr)
Revenue 988.09
Operating Expense 1020.90
Net Profit -5.71
Net Profit Margin (%) -0.57
Earnings Per Share (EPS) -0.97
EBITDA 234.51
Effective Tax Rate (%) 171.25
Particulars MAR 2021 (Values in Cr)
Revenue 856.58
Operating Expense 863.59
Net Profit -4.40
Net Profit Margin (%) -0.51
Earnings Per Share (EPS) -0.74
EBITDA 203.63
Effective Tax Rate (%) 127.29
Particulars MAR 2020 (Values in Cr)
Revenue 751.84
Operating Expense 807.42
Net Profit -20.79
Net Profit Margin (%) -2.76
Earnings Per Share (EPS) -4.20
EBITDA 177.98
Effective Tax Rate (%) -6.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 83.36
ROE % 13.24
ROCE % 14.76
Total Debt to Total Equity 2.01
EBITDA Margin 21.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 67.63
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.46
EBITDA Margin 23.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 65.67
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.52
EBITDA Margin 23.06
Particulars MAR 2020 (Values in Cr)
Book Value / Share 69.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.85
EBITDA Margin 22.80
Particulars MAR 2019 (Values in Cr)
Book Value / Share 72.07
ROE % -9.46
ROCE % 3.89
Total Debt to Total Equity 3.45
EBITDA Margin 21.55
Particulars MAR 2023 (Values in Cr)
Book Value / Share 82.26
ROE % 11.57
ROCE % 14.16
Total Debt to Total Equity 1.94
EBITDA Margin 22.17
Particulars MAR 2022 (Values in Cr)
Book Value / Share 72.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.25
EBITDA Margin 24.57
Particulars MAR 2021 (Values in Cr)
Book Value / Share 71.55
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.39
EBITDA Margin 23.77
Particulars MAR 2020 (Values in Cr)
Book Value / Share 70.15
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.83
EBITDA Margin 23.67
Particulars MAR 2019 (Values in Cr)
Book Value / Share 72.58
ROE % -7.07
ROCE % 4.50
Total Debt to Total Equity 3.49
EBITDA Margin 23.78
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 18.19
Total Assets 1824.06
Total Liabilities 1824.06
Total Equity 681.93
Share Outstanding 59086919
Price to Book Ratio 0.67
Return on Assets (%) 2.60
Return on Capital (%) 3.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 21.47
Total Assets 1800.79
Total Liabilities 1800.79
Total Equity 600.86
Share Outstanding 59086919
Price to Book Ratio 0.91
Return on Assets (%) -0.11
Return on Capital (%) -0.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.60
Total Assets 1818.44
Total Liabilities 1818.44
Total Equity 603.41
Share Outstanding 59086919
Price to Book Ratio 1.01
Return on Assets (%) -0.17
Return on Capital (%) -0.2
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.58
Total Assets 1870.00
Total Liabilities 1870.00
Total Equity 640.63
Share Outstanding 59086919
Price to Book Ratio 0.31
Return on Assets (%) -1.13
Return on Capital (%) -1.27
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 29.96
Total Assets 1923.96
Total Liabilities 1923.96
Total Equity 587.81
Share Outstanding 47569190
Price to Book Ratio 0.54
Return on Assets (%) 1.50
Return on Capital (%) 1.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.95
Total Assets 1788.27
Total Liabilities 1788.27
Total Equity 675.34
Share Outstanding 59086919
Price to Book Ratio 0.67
Return on Assets (%) 2.37
Return on Capital (%) 2.78
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 9.37
Total Assets 1802.91
Total Liabilities 1802.91
Total Equity 632.55
Share Outstanding 59086919
Price to Book Ratio 0.91
Return on Assets (%) -0.31
Return on Capital (%) -0.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.95
Total Assets 1817.19
Total Liabilities 1817.19
Total Equity 638.69
Share Outstanding 59086919
Price to Book Ratio 1.01
Return on Assets (%) -0.24
Return on Capital (%) -0.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 8.83
Total Assets 1860.20
Total Liabilities 1860.20
Total Equity 644.60
Share Outstanding 59086919
Price to Book Ratio 0.31
Return on Assets (%) -1.11
Return on Capital (%) -1.24
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 29.08
Total Assets 1912.77
Total Liabilities 1912.77
Total Equity 590.28
Share Outstanding 47569190
Price to Book Ratio 0.54
Return on Assets (%) 2.01
Return on Capital (%) 2.22
Particulars MAR 2023 (Values in Cr)
Net Income 113.16
Cash from Operations 194.61
Cash from Investing -13.36
Cash from Financing -185.65
Net change in Cash -4.40
Free Cash Flow 207.39
Particulars MAR 2022 (Values in Cr)
Net Income 12.53
Cash from Operations 150.27
Cash from Investing 4.77
Cash from Financing -140.87
Net change in Cash 14.16
Free Cash Flow 168.68
Particulars MAR 2021 (Values in Cr)
Net Income 18.00
Cash from Operations 134.94
Cash from Investing -10.17
Cash from Financing -123.74
Net change in Cash 1.02
Free Cash Flow 138.85
Particulars MAR 2020 (Values in Cr)
Net Income -19.77
Cash from Operations 125.23
Cash from Investing -9.09
Cash from Financing -133.25
Net change in Cash -17.11
Free Cash Flow 135.98
Particulars MAR 2019 (Values in Cr)
Net Income -33.25
Cash from Operations -64.39
Cash from Investing -12.46
Cash from Financing 99.62
Net change in Cash 22.75
Free Cash Flow -49.14
Particulars MAR 2023 (Values in Cr)
Net Income 105.84
Cash from Operations 182.67
Cash from Investing -13.68
Cash from Financing -168.40
Net change in Cash 0.57
Free Cash Flow 195.94
Particulars MAR 2022 (Values in Cr)
Net Income 9.68
Cash from Operations 136.25
Cash from Investing 2.75
Cash from Financing -139.59
Net change in Cash -0.57
Free Cash Flow 154.63
Particulars MAR 2021 (Values in Cr)
Net Income 16.11
Cash from Operations 135.03
Cash from Investing -10.17
Cash from Financing -123.74
Net change in Cash 1.11
Free Cash Flow 138.94
Particulars MAR 2020 (Values in Cr)
Net Income -19.56
Cash from Operations 123.16
Cash from Investing -10.15
Cash from Financing -133.25
Net change in Cash -20.24
Free Cash Flow 134.32
Particulars MAR 2019 (Values in Cr)
Net Income -24.00
Cash from Operations -74.62
Cash from Investing -2.34
Cash from Financing 99.62
Net change in Cash 22.65
Free Cash Flow -59.37
Company Name Price P/E P/B Market Cap 52 Week Low/High
IND SWIFT LABORATORIES LT 130.45 5.20 1.03 770.79 82.00 / 147.10
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
IND SWIFT LABORATORIES LT 130.45 5.30 1.04 770.79 82.00 / 147.10
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 135.00
  • 26 Days 129.40
  • 10 Days 134.10
  • 50 Days 122.10
  • 12 Days 134.40
  • 100 Days 117.80
  • 20 Days 130.90
  • 200 Days 92.40
136.71
PIVOT
First Resistance 141.07
Second Resistance 147.18
Third Resistance 151.54
First Support 130.60
Second Support 126.24
Third Support 120.13
RSI 50.41
MACD 4.94
Commodity Channel Index (CCI) 14.53
ADX 39.90
Williams % R -81.20

Over 1 Month

down

16.33

Over 3 Months

down

9.90

Over 6 Months

down

22.10

Over 1 Year

down

43.32

Over 3 Years

down

2.37

Over 5 Years

down

33.84

IND SWIFT LABORATORIES LT Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

IND SWIFT LABORATORIES LT Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
56.73
Promoter Holdings
42.0
FII
1.26
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Essix Biosciences Limited Shareholding of Promoter and Promoter Group 2.2327507E7 37.79
Wilson Holdings Private Limited Public Shareholding 5865502.0 9.93
Ashokkumar Chandak Public Shareholding 2263147.0 3.83
N.r. Munjal Shareholding of Promoter and Promoter Group 920724.0 1.56
Sri Ganesh Biotech Private Limited Public Shareholding 796006.0 1.35
Sharwan Singh Guleria Public Shareholding 732800.0 1.24
Conquer Investment & Finance Pvt. Ltd. Public Shareholding 697055.0 1.18
Patanjali Real Estate Provate Limited Public Shareholding 631603.0 1.07
Anirudh Damani Public Shareholding 611000.0 1.03
Rishav Mehta Shareholding of Promoter and Promoter Group 454545.0 0.77
Himanshu Jain Shareholding of Promoter and Promoter Group 406961.0 0.69
Neera Mehta Shareholding of Promoter and Promoter Group 249000.0 0.42
S. R. Mehta Shareholding of Promoter and Promoter Group 233600.0 0.4
Gopal Munjal Shareholding of Promoter and Promoter Group 60900.0 0.1
V.r. Mehta Shareholding of Promoter and Promoter Group 52900.0 0.09
Sunita Jain Shareholding of Promoter and Promoter Group 46100.0 0.08
Ravi Mehta Shareholding of Promoter and Promoter Group 12000.0 0.02
Nidhi Munjal Shareholding of Promoter and Promoter Group 12000.0 0.02
Neeta Munjal Shareholding of Promoter and Promoter Group 12000.0 0.02
Meenakshi Mehta Shareholding of Promoter and Promoter Group 12000.0 0.02
Sahil Munjal Shareholding of Promoter and Promoter Group 6766.0 0.01
Ishav Mehta Shareholding of Promoter and Promoter Group 3000.0 0.01
Divya Munjal Shareholding of Promoter and Promoter Group 3000.0 0.01
Bhanavi Mehta Shareholding of Promoter and Promoter Group 3000.0 0.01
Ind Swift Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Annie Mehta Shareholding of Promoter and Promoter Group 2780.0 0.0

IND SWIFT LABORATORIES LT

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2011-09-20 1.0 Final 2011-09-22 Equity shares 2010-09-16 1.0 Final 2010-09-20 Equity shares 2009-09-17 1.0 Final 2009-09-21 Equity shares 2008-09-18 1.0 Final 2008-09-22 Equity shares 2007-09-21 1.0 Final 2007-09-25 Equity shares 2005-09-22 0.0 Final 2005-09-26 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About IND SWIFT LABORATORIES LT

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by IND SWIFT LABORATORIES LT

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ind-Swift Laboratories Ltd?

Answer Field

The share price of Ind-Swift Laboratories Ltd for NSE is ₹ 134.16 and for BSE is ₹ 134.2.

What is the Market Cap of Ind-Swift Laboratories Ltd?

Answer Field

The market cap of Ind-Swift Laboratories Ltd for NSE is ₹ 7,92.71 Cr. and for BSE is ₹ 7,92.94 Cr. as of now.

What is the 52 Week High and Low of Ind-Swift Laboratories Ltd?

Answer Field

The 52 Week High and Low of Ind-Swift Laboratories Ltd for NSE is ₹ 147.20 and ₹ 81.85 and for BSE is ₹ 147.10 and ₹ 82.00.

How to Buy Ind-Swift Laboratories Ltd share?

Answer Field

You can trade in Ind-Swift Laboratories Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ind-Swift Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 43.32%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader